E. W. Prosser Thomas

Type I IFNs Enhance the Terminal Differentiation of Dendritic Cells

Thomas Luft, Ken C. Pang, E. W. Prosser Thomas et al. · The Journal of Immunology · 1998 · 604 citations

Mature Dc, Immunology, Immune Regulation +16

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Reuben Benjamin, Charlotte Graham, Deborah Yallop et al. · The Lancet · 2020 · 344 citations · Full text

Hematological Malignancy, Cell Therapy, Transplantation +9

TREATMENT OF LUPUS VULGARIS WITH CALCIFEROL

G. B. Dowling, E. W. Prosser Thomas · The Lancet · 1946 · 73 citations

Lupus, Lupus Nephritis, Therapeutic Efficacy +3

Zoledronic acid (ZA) effectively inhibits cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (Let): 12 mos BMD results of the Z-FAST trial

Adam Brufsky, W G Harker, J. Thaddeus Beck et al. · Journal of Clinical Oncology · 2005 · 54 citations

Breast Oncology, Pharmacotherapy, Z-fast Trial +22

Free and total magnesium in lymphocytes of migraine patients — effect of magnesium-rich mineral water intake

Jean Thomas, Jean‐Marc Millot, Stéphane Sebille et al. · Clinica Chimica Acta · 2000 · 46 citations

Pharmacology, Total Magnesium, Neurology +1